Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.66 |
| ▸ | GAA | P10253 | 5/20 | 0.66 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | HPGD | P15428 | 3/20 | 0.66 |
| ▸ | GLA | P06280 | 2/20 | 0.66 |
| ▸ | CASP1 | P29466 | 1/20 | 0.66 |
| ▸ | CASP7 | P55210 | 1/20 | 0.66 |
| ▸ | ATM | Q13315 | 1/20 | 0.66 |
| ▸ | CFTR | P13569 | 2/20 | 0.58 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 3/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | FLT1 | P17948 | 1/20 | 0.50 |
| ▸ | FLT4 | P35916 | 1/20 | 0.50 |
| ▸ | KDR | P35968 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL267531 | 0.85 | ABL1 (0.74) | ABL1KDM4EALDH1A1GAAHSD17B10 | |
| SCHEMBL21857090 | 0.83 | ABL1 (0.70) | ABL1KDM4EALDH1A1GAAHSD17B10 | |
| SCHEMBL6100118 | 0.82 | ABL1 (0.70) | ABL1KDM4EALDH1A1GAAHSD17B10 | |
| SCHEMBL8205593 | 0.82 | ABL1 (0.70) | ABL1KDM4EALDH1A1GAAHSD17B10 | |
| SCHEMBL608814 | 0.81 | ABL1 (0.68) | ABL1KDM4EALDH1A1MAPTHPGD | |
| SCHEMBL29400478 | 0.81 | GAA (0.70) | ABL1KDM4EALDH1A1GAAHSD17B10 | |
| SCHEMBL2926607 | 0.81 | GAA (0.70) | ABL1KDM4EALDH1A1GAAHSD17B10 | |
| SCHEMBL1189663 | 0.81 | ABL1 (0.68) | ABL1KDM4EALDH1A1GAAHSD17B10 | |
| SCHEMBL1186026 | 0.81 | ABL1 (0.68) | ABL1KDM4EALDH1A1GAAHSD17B10 | |
| SCHEMBL11177948 | 0.80 | ABL1 (0.65) | ABL1KDM4EALDH1A1GAAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 654 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114507192-A | Preparation method of intermediate for preparing tianeptine sodium | 上海微巨实业有限公司 | 2022-05-17 | — | — | CN | claimed |
| US-4288362-A | Monoazo pigments containing a quinazo linonylacetoacetanilide coupling component | BAYER AKTIENGESELLSCHAFT (DE) | 1981-09-08 | — | — | US | claimed |
| EP-4734979-A2 | TMEM175 AGONISTS, COMPOSITIONS, AND METHODS OF USE | Caraway Therapeutics, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260070932-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | ANNEXON INC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12509474-B2 | Inhibitors of complement factors and uses thereof | ANNEXON, INC. (US) | 2025-12-30 | — | — | US | disclosed |
| EP-4582423-A1 | NOVEL TRICYCLIC DERIVATIVE COMPOUND AND USES THEREOF | Hanmi Pharm. Co., Ltd. (KR) | 2025-07-09 | — | — | EP | disclosed |
| US-20250206724-A1 | SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2025-06-26 | — | — | US | disclosed |
| WO-2025128938-A1 | BENZOTHIAZOLE DERIVATIVES USEFUL AS RXFP1 RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2025-06-19 | — | — | WO | disclosed |
| US-20250197413-A1 | RXFP1 RECEPTOR AGONISTS | ELI LILLY AND COMPANY | 2025-06-19 | — | — | US | disclosed |
| CN-120077041-A | Tricyclic derivative compounds and use thereof | 韩美药品株式会社 | 2025-05-30 | — | — | CN | disclosed |
| CN-119143671-B | Method for simply and conveniently synthesizing quinolinone derivative through one-pot method of carboinsertion reaction | 九洲药业(杭州)有限公司 | 2025-05-16 | — | — | CN | disclosed |
| US-4225489-A | Heterocyclic azo dyes and pigments containing 4-quinazolinone moieties | BAYER AKTIENGESELLSCHAFT (DE) | 1980-09-30 | — | — | US | disclosed |
| US-4198350-A | Amination/demethylation process | STANDARD OIL COMPANY (INDIANA) (US) | 1980-04-15 | — | — | US | disclosed |
| US-4163059-A | Pesticidally active 4,5-dichloro-3-substituted-phenylimino-1,2-dithiolenes | BAYER AKTIENGESELLSCHAFT (DE) | 1979-07-31 | — | — | US | disclosed |
| US-4150019-A | COLORFAST, HEAT RESISTANT, MIGRATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1979-04-17 | — | — | US | disclosed |
| US-4083842-A | USEFUL AS PIGMENTS FOR SYNTHETIC POLYMERS | SANDOZ LTD. (CH) | 1978-04-11 | — | — | US | disclosed |
| US-4014863-A | LACQUERS, PRINTING INKS, PAINTS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-29 | — | — | US | disclosed |
| US-4000275-A | BENZIMIDAZO(2,1-B) QUINAZOLIN-12(6H)ONES | ELI LILLY AND COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-3989689-A | ANTIINFLAMMATORY | CIBA-GEIGY CORPORATION (US) | 1976-11-02 | — | — | US | disclosed |
| US-3949081-A | 4-Carbamoyl-1-benzazepines as antiinflammatory agents | CIBA-GEIGY CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250197413-A1 | RXFP1 RECEPTOR AGONISTS | RXFP1, RXFP3, RXFP2 | ABL1 1785/4885KDM4E 3828/4885ALDH1A1 1973/4885 |
| US-20250206724-A1 | SUBSTITUTED 3-AMINO INDAZOLE DERIVATIVES AS KINASE INHIBITORS | CDK1, CDK11A, CDK3 | ABL1 333/4885KDM4E 1212/4885ALDH1A1 4385/4885 |
| US-12509474-B2 | Inhibitors of complement factors and uses thereof | SSB, UACA, CFH | ABL1 2003/4885KDM4E 2913/4885ALDH1A1 3178/4885 |
| US-20260070932-A1 | INHIBITORS OF COMPLEMENT FACTORS AND USES THEREOF | CFH, CFB, C5 | ABL1 2557/4885KDM4E 4178/4885ALDH1A1 3094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.